Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DPP4 | P27487 | 2/20 | 0.39 |
| ▸ | CRHR1 | P34998 | 14/20 | 0.38 |
| ▸ | CNR1 | P21554 | 2/20 | 0.35 |
| ▸ | CNR2 | P34972 | 1/20 | 0.35 |
| ▸ | NPC1 | O15118 | 1/20 | 0.32 |
| ▸ | HTR2C | P28335 | 1/20 | 0.32 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1660727 | 0.78 | CRHR1 (0.45) | DPP4CRHR1 | |
| SCHEMBL1659930 | 0.76 | NPC1 (0.38) | DPP4CRHR1CNR1CNR2NPC1 | |
| SCHEMBL12789037 | 0.75 | CNR1 (0.40) | DPP4CNR1CNR2NPC1 | |
| SCHEMBL1661747 | 0.75 | CRHR1 (0.44) | CRHR1 | |
| SCHEMBL11903989 | 0.74 | CRHR1 (0.42) | CRHR1 | |
| SCHEMBL1662899 | 0.73 | CRHR1 (0.41) | DPP4CRHR1 | |
| SCHEMBL1660725 | 0.70 | CRHR1 (0.51) | CRHR1 | |
| SCHEMBL12731280 | 0.70 | NPC1 (0.46) | DPP4CRHR1NPC1 | |
| SCHEMBL1660803 | 0.70 | LMNA (0.48) | DPP4NPC1 | |
| SCHEMBL1661745 | 0.70 | MAPT (0.45) | DPP4CNR1NPC1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20110086898-A1 | PYRAZOLOOXAZOLE COMPOUND | EISAI R&D MANAGEMENT CO., LTD. (JP) | 2011-04-14 | — | — | US | disclosed |
| US-20110086898-A1 | PYRAZOLOOXAZOLE COMPOUND | EISAI R&D MANAGEMENT CO., LTD. (JP) | 2011-04-14 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110086898-A1 | PYRAZOLOOXAZOLE COMPOUND | CRHR1, MC2R, CRHR2 | DPP4 1019/4885CRHR1 1/4885CNR1 6/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.